Package 0310-1745-01

{"route": ["SUBCUTANEOUS"], "spl_id": "901977cc-c730-4b8b-9faf-ca24afc3589a", "openfda": {"nui": ["N0000193803", "N0000193802"], "unii": ["71492GE1FX"], "rxcui": ["1989104", "1989109", "2205632", "2205634", "2679499", "2679502"], "spl_set_id": ["da6aca1a-19ed-44a4-abb7-696c7d58b784"], "pharm_class_epc": ["Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]"], "pharm_class_moa": ["Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CARTRIDGE in 1 CARTON (0310-1745-01)  / .5 mL in 1 CARTRIDGE", "package_ndc": "0310-1745-01", "marketing_start_date": "20240603"}, {"sample": true, "description": "1 CARTRIDGE in 1 CARTON (0310-1745-95)  / .5 mL in 1 CARTRIDGE", "package_ndc": "0310-1745-95", "marketing_start_date": "20240603"}], "brand_name": "FASENRA", "product_id": "0310-1745_901977cc-c730-4b8b-9faf-ca24afc3589a", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]", "Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]"], "product_ndc": "0310-1745", "generic_name": "Benralizumab", "labeler_name": "AstraZeneca Pharmaceuticals LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FASENRA", "active_ingredients": [{"name": "BENRALIZUMAB", "strength": "10 mg/.5mL"}], "application_number": "BLA761070", "marketing_category": "BLA", "marketing_start_date": "20240405", "listing_expiration_date": "20261231"}